Londax CORP

8-K10-Q10-K

Market Movers (8-K)

See all →
OTC.Pink
Londax Corp. files an amendment to its Form 8-K to correct details regarding director resignations and confirm the acquisition of control by Alpha Investment Inc., with Jon S. Cummings IV appointed as CEO.
OTC.Pink
Londax Corp. has announced a change of control with Alpha Investment Inc. acquiring approximately 90% of its common stock, leading to a transition in executive leadership and board composition.
OTC.Pink
Londax Corp. announced significant leadership changes, including new interim CEO and CFO appointments, and the relocation of its principal executive offices to Cyprus, citing cost reduction and efficiency.
Worse than expected
OTC.Pink
Londax Corp. announced the appointment of Ms. Ani Vashakidze, a 27-year-old marketing director, as a new director to its Board.
OTC.Pink
A director of Londax Corp. voluntarily cancelled 3 million restricted shares without compensation, significantly reducing the company's total outstanding shares and altering its capital structure.
Better than expected
OTC.Pink
Londax Corp. announced the appointment of Mr. Giorgi Loloshvili, owner of an IT company, as a new director to its Board, effective July 11, 2025.

Quarterly Earnings (10-Q)

OTC.Pink
Londax Corp. transitioned to a subscription-based revenue model in Q3 2026, resulting in a sharp revenue decline and a going concern warning.
Worse than expected
Capital raise
OTC.Pink
Londax Corp. reported a significant net loss and revenue decline for the quarter ended November 30, 2025, driven by a shift to a subscription-based revenue model and increased operating expenses.
Worse than expected
Capital raise
OTC.Pink
Londax Corp. posted a significant net loss of $11,943 for Q1 2026, down from a $10,297 profit year-over-year, as revenue plummeted 87.9% due to a shift to a subscription-based model, while also announcing key management changes.
Worse than expected
Capital raise
OTC.Pink
Londax Corp., a software development and IT consulting firm, reported significant revenue growth and a substantial positive turnaround in cash flow from operations for the nine months ended February 28, 2025, despite acknowledging substantial doubt about its ability to continue as a going concern and ineffective disclosure controls.
Better than expected
Capital raise
OTC.Pink
Londax Corp., a software development and IT consulting firm, reported substantial revenue and net income growth for the six months ended November 30, 2024, but faces significant liquidity challenges and a 'going concern' warning due to its limited cash and reliance on future capital raises.
Worse than expected
Capital raise

Annual Reports (10-K)

OTC.Pink
Londax Corp., a developmental-stage IT consulting and software firm, reported a 162.5% revenue increase for FY2025, yet faces substantial doubt about its ability to continue as a going concern due to accumulated losses and negative working capital.
Capital raise
Worse than expected